← Leaderboards
Pamela U Freda
Columbia University Health Sciences
$13,039,453
Attributed
$13,039,453
Total exposure
13
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,039,453 · 13
By mechanism
R01$9,602,739 · 4
K24$1,516,415 · 1
M01$1,015,087 · 5
K08$512,912 · 1
R56$228,800 · 1
R03$163,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Gabrielle Pagewilson$600,000
Others in their field
Top investigators on “Acromegaly”
- Shlomo Melmed · Cedars-Sinai Medical Center$3,887,308
- John J Kopchick · Ohio University Athens$3,834,473
- Gabriel Zada · University Of Southern California$2,620,656
- Adiba Zanghi · Elixera, Inc.$2,095,403
- Richard Scott Struthers · Neurocrine Biosciences, Inc.$1,774,224
- Laurence Katznelson · Massachusetts Institute Of Technology$1,706,437
Research focus
AcromegalyClinical ResearchSomatotropinEvaluationBody CompositionProspectiveBaseLinkCohortMetabolicOperative Surgical ProceduresInsulin-Like Growth Factor ILeadHuman SubjectPituitary GlandLipidsBiochemicalGhrelinNovel StrategiesCohort StudiesCardiovascular Risk FactorInsulin ResistanceMorbidity - Disease RatePituitary Neoplasms
Grant awards (54)
Central Mediation of Growth Hormone Effects in Humans$609,967
R01 · FY2025 · DK · contact PI
Central Mediation of Growth Hormone Effects in Humans$577,987
R01 · FY2024 · DK · contact PI
Central Mediation of Growth Hormone Effects in Humans$602,070
R01 · FY2023 · DK · contact PI
New Approaches to the Evaluation and Treatment of Acromegaly$585,608
R01 · FY2020 · DK · contact PI
New Approaches to the Evaluation and Treatment of Acromegaly$585,608
R01 · FY2019 · DK · contact PI
New Approaches to the Evaluation and Treatment of Acromegaly$585,608
R01 · FY2018 · DK · contact PI
New Approaches to the Evaluation and Treatment of Acromegaly$585,608
R01 · FY2017 · DK · contact PI
New Approaches to the Evaluation and Treatment of Acromegaly$228,800
R56 · FY2015 · DK · contact PI
Prospective Study of Clinically Non-functioning Pituitary Adenomas$341,692
R01 · FY2014 · NS · contact PI
New Approaches to the Evaluation and Treatment of Acromegaly$162,905
K24 · FY2014 · DK · contact PI
New Approaches to the Evaluation and Treatment of Acromegaly$341,091
R01 · FY2013 · DK · contact PI
Prospective Study of Clinically Non-functioning Pituitary Adenomas$333,064
R01 · FY2013 · NS · contact PI
New Approaches to the Evaluation and Treatment of Acromegaly$163,765
K24 · FY2013 · DK · contact PI
New Approaches to the Evaluation and Treatment of Acromegaly$353,463
R01 · FY2012 · DK · contact PI
Prospective Study of Clinically Non-functioning Pituitary Adenomas$345,144
R01 · FY2012 · NS · contact PI
New Approaches to the Evaluation and Treatment of Acromegaly$164,620
K24 · FY2012 · DK · contact PI
New Approaches to the Evaluation and Treatment of Acromegaly$403,327
R01 · FY2011 · DK · contact PI
Prospective Study of Clinically Non-functioning Pituitary Adenomas$345,144
R01 · FY2011 · NS · contact PI
New Approaches to the Evaluation and Treatment of Acromegaly$165,439
K24 · FY2011 · DK · contact PI
New Approaches to the Evaluation and Treatment of Acromegaly$473,889
R01 · FY2010 · DK · contact PI
Prospective Study of Clinically Non-functioning Pituitary Adenomas$351,677
R01 · FY2010 · NS · contact PI
New Approaches to the Evaluation and Treatment of Acromegaly$162,166
K24 · FY2010 · DK · contact PI
New Approaches to the Evaluation and Treatment of Acromegaly$36,473
R01 · FY2010 · DK · contact PI
New Approaches to the Evaluation and Treatment of Acromegaly$29,922
R01 · FY2010 · DK · contact PI
New Approaches to the Evaluation and Treatment of Acromegaly$383,012
R01 · FY2009 · DK · contact PI
New Approaches to Evaluation and Treatment of Acromegaly$143,572
K24 · FY2009 · DK · contact PI
New Approaches to Evaluation and Treatment of Acromegaly$331,643
R01 · FY2008 · DK · contact PI
New Approaches to Evaluation and Treatment of Acromegaly$140,703
K24 · FY2008 · DK · contact PI
New Approaches to Evaluation and Treatment of Acromegaly$338,412
R01 · FY2007 · DK · contact PI
New Approaches to Evaluation and Treatment of Acromegaly$137,918
K24 · FY2007 · DK · contact PI
New Approaches to Evaluation and Treatment of Acromegaly$348,518
R01 · FY2006 · DK · contact PI
New Approaches to Evaluation and Treatment of Acromegaly$135,213
K24 · FY2006 · DK · contact PI
New Approaches to Evaluation and Treatment of Acromegaly$356,906
R01 · FY2005 · DK
New Approaches to Evaluation and Treatment of Acromegaly$140,114
K24 · FY2005 · DK
New Approaches to Evaluation and Treatment of Acromegaly$356,906
R01 · FY2004 · DK
Nalmefene Testing$1,111
M01 · FY2004 · RR
NEW APPROACHES TO EVALUATION AND TREATMENT OF ACROMEGALY$131,004
K08 · FY2003 · DK
NEW APPROACHES TO EVALUATION AND TREATMENT OF ACROMEGALY$81,750
R03 · FY2003 · DK
OUTCOME OF SURGICAL THERAPY FOR ACROMEGALY$192,910
M01 · FY2002 · RR
SEN 3614:RANDOM ,DBL BLIND,PLACEBO CONT STUDY OF B2036 PEG IN TREAT A$192,910
M01 · FY2002 · RR
NEW APPROACHES TO EVALUATION AND TREATMENT OF ACROMEGALY$131,004
K08 · FY2002 · DK
NEW APPROACHES TO EVALUATION AND TREATMENT OF ACROMEGALY$81,750
R03 · FY2002 · DK
OUTCOME OF SURGICAL THERAPY FOR ACROMEGALY$192,910
M01 · FY2001 · RR
SEN 3614:RANDOM ,DBL BLIND,PLACEBO CONT STUDY OF B2036 PEG IN TREAT A$192,910
M01 · FY2001 · RR
NEW APPROACHES TO EVALUATION AND TREATMENT OF ACROMEGALY$125,452
K08 · FY2001 · DK
OUTCOME OF SURGICAL THERAPY FOR ACROMEGALY$0
M01 · FY2001 · RR
SEN 3614:RANDOM ,DBL BLIND,PLACEBO CONT STUDY OF B2036 PEG IN TREAT A$0
M01 · FY2001 · RR
NEW APPROACHES TO EVALUATION AND TREATMENT OF ACROMEGALY$125,452
K08 · FY2000 · DK
GONADOTROPIN RESPONSE TO ACTH$121,168
M01 · FY2000 · RR
PILOT STUDY OF CABERGOLINE TREATMENT FOR ACROMEGALY$121,168
M01 · FY2000 · RR
SEN 3614:RANDOM ,DBL BLIND,PLACEBO CONT STUDY OF B2036 PEG IN TREAT A$0
M01 · FY2000 · RR
SEN 3614:RANDOM ,DBL BLIND,PLACEBO CONT STUDY OF B2036 PEG IN TREAT A$0
M01 · FY2000 · RR
OUTCOME OF SURGICAL THERAPY FOR ACROMEGALY$0
M01 · FY2000 · RR
OUTCOME OF SURGICAL THERAPY FOR ACROMEGALY$0
M01 · FY2000 · RR